113 results
Page 2 of 6
8-K
EX-99.1
f4e8s4mk ev
23 Sep 22
InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update
4:53pm
8-K
EX-10.1
jrt51zr 1mz
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-99.1
qlvl26r5xg8k6
26 Jul 22
InMed Announces Update on Phase 2 Clinical Trial Investigating INM-755 Cannabinol Cream for Epidermolysis Bullosa
1:32pm
8-K
EX-10.1
nbl543y071q eu
19 Jul 22
InMed Announces Appointment of Chief Operating Officer
7:43pm
424B3
49pkp73zyf m2ra
6 Jul 22
Prospectus supplement
2:43pm
8-K
EX-10.1
5k6clzsfdzn
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.2
r9hbmjclxspa6om
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
424B5
sggsklzm2nvp 8c
3 Jun 22
Prospectus supplement for primary offering
9:45pm
8-K
EX-99.1
4w7d1j4 0ijpor
18 May 22
InMed Pharmaceuticals Reports Third Quarter Fiscal 2022 Financial Results and Provides Business Update
1:34pm
8-K
EX-99.1
mqtw9 xogg14m5f5
28 Apr 22
Regulation FD Disclosure
2:35pm
424B3
lwlmb1
25 Apr 22
Prospectus supplement
5:02pm
8-K
EX-10.1
fok2l tja0i08v4yfpmt
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm
424B3
n94b8px
7 Apr 22
Prospectus supplement
4:46pm